Company intelligence / Profile preview

Texas Advanced Therapies

San Antonio, Texas, United States

Ownership: Private
Employees: ~70
Development stage: Other

Overview

BBG Advanced Therapies, as a division of BioBridge Global, delivers integrated starting material collection (including via a world-first mobile leukapheresis platform), analytical testing, and GMP manufacturing, accelerating and decentralizing clinical access to cell and gene therapies in underserved populations. It does not develop its own drug candidates but enables clients' therapies from bench research through commercialization.

Therapeutic areas: OncologyNeurologyImmunologyRare Diseases
Modalities: Cell therapyGene therapy
Industry: Contract Research Organization

Partnerships

Collaborates with major biopharma clientsAcademic institutionsHealthcare systemsVelocityTX innovation network

Beyond the preview

Go deeper on Texas Advanced Therapies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Texas Advanced Therapies.

Explore the full profile